NPS PHARMACEUTICALS INC 4
4 · NPS PHARMACEUTICALS INC · Filed Nov 13, 2014
Insider Transaction Report
Form 4
Selisker Rachel R
Director
Transactions
- Sale
Common Stock
2014-11-11$29.50/sh−15,188$448,087→ 9,900 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.52, inclusive. The reporting person undertakes to provide to NPS Pharmaceuticals, Inc., any security holder of NPS Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.